ABA Chemicals (SZSE:300261) Change In Working Capital : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is ABA Chemicals Change In Working Capital?

ABA Chemicals's change in working capital for the quarter that ended in Mar. 2024 was ¥0 Mil.

ABA Chemicals's change in working capital for the fiscal year that ended in Dec. 2023 was ¥-153 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

ABA Chemicals Change In Working Capital Historical Data

The historical data trend for ABA Chemicals's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABA Chemicals Change In Working Capital Chart

ABA Chemicals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-184.92

18.88

64.11

-340.24

-153.37

ABA Chemicals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

ABA Chemicals Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

ABA Chemicals Change In Working Capital Related Terms

Thank you for viewing the detailed overview of ABA Chemicals's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ABA Chemicals (SZSE:300261) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » ABA Chemicals Corp (SZSE:300261) » Definitions » Change In Working Capital

Traded in Other Exchanges

N/A

Address

No. 18 Dongfang East Road, Port Development Zone, Taicang Port, Petrochemical District, Jiangsu Province, Shanghai, CHN, 215433

Website

http://www.abachem.com

ABA Chemicals Corp is a Chinese company integrating research and development, production and sales in the field of life sciences. It is principally engaged in the production of advanced intermediates, active pharmaceutical ingredients (APIs), and pesticide products. Some of the products offered by the company are Acridine, Snail, Fluorourea, Pentanoyl chloride, Fondaparinux, and Levetiracetam.

Executives

Han Xue	Supervisors
Huang Liang	Supervisors
Ma Li Fan	Directors, executives
Cai Tong	Directors, executives
Mao Hai Feng	Directors, executives
Wang Zhuo Ying	Directors, Directors, and Executives
Han Jie	Supervisors
Liu Zhi Hui	Supervisors
Yang Ji Dong	Supervisors
Zhu Pei Fang	Securities Affairs Representative
Li Hang	Supervisors
Li Yuan Xing	Executives
	Executives
Qin Dong Guang	Executives
Wang Sheng Hong	Director

ABA Chemicals (SZSE:300261) Headlines

No Headlines